Literature DB >> 24694945

Does active dissemination of evidence result in faster knowledge transfer than passive diffusion?: An analysis of trends of the management of pediatric asthma and croup in US emergency departments from 1995 to 2009.

Jane F Knapp1, Stephen D Simon, Vidya Sharma.   

Abstract

OBJECTIVE: This study aimed to compare knowledge transfer (KT) in the emergency department (ED) management of pediatric asthma and croup by measuring trends in corticosteroid use for both conditions in EDs.
METHODS: A retrospective, cross-sectional study of the National Hospital Ambulatory Medical Care Survey data between 1995 and 2009 of corticosteroid use at ED visits for asthma or croup was conducted. Odds ratios (OR) were calculated using logistic regression. Trends over time were compared using an interaction term between disease and year and were adjusted for all other covariates in the model. We included children aged 2 to 18 years with asthma who received albuterol and were triaged emergent/urgent. Children aged between 3 months to 6 years with croup were included. The main outcome measure was the administration of corticosteroids in the ED or as a prescription at the ED visit.
RESULTS: The corticosteroid use in asthma visits increased from 44% to 67% and from 32% to 56% for croup. After adjusting for patient and hospital factors, this trend was significant both for asthma (OR, 1.07; 95% confidence interval [CI], 1.04-1.10) and croup (OR, 1.07; 95% CI, 1.03-1.12). There was no statistical difference between the 2 trends (P = 0.69). Hospital location in a metropolitan statistical area was associated with increased corticosteroid use in asthma (OR, 1.76; 95% CI, 1.10-2.82). Factors including sex, ethnicity, insurance, or region of the country were not significantly associated with corticosteroid use.
CONCLUSIONS: During a 15-year period, knowledge transfer by passive diffusion or active guideline dissemination resulted in similar trends of corticosteroid use for the management of pediatric asthma and croup.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24694945     DOI: 10.1097/PEC.0000000000000099

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

1.  Comparing traditional and participatory dissemination of a shared decision making intervention (ADAPT-NC): a cluster randomized trial.

Authors:  Hazel Tapp; Andrew McWilliams; Thomas Ludden; Lindsay Kuhn; Yhenneko Taylor; Thamara Alkhazraji; Jacquie Halladay; Diane Derkowski; Sveta Mohanan; Michael Dulin
Journal:  Implement Sci       Date:  2014-10-29       Impact factor: 7.327

2.  Shedding light on conditions for the successful passive dissemination of recommendations in primary care: a mixed methods study.

Authors:  Isabelle Vedel; Melanie Le Berre; Nadia Sourial; Geneviève Arsenault-Lapierre; Howard Bergman; Liette Lapointe
Journal:  Implement Sci       Date:  2018-10-16       Impact factor: 7.327

3.  Effectiveness of knowledge brokering and recommendation dissemination for influencing healthcare resource allocation decisions: A cluster randomised controlled implementation trial.

Authors:  Mitchell N Sarkies; Lauren M Robins; Megan Jepson; Cylie M Williams; Nicholas F Taylor; Lisa O'Brien; Jenny Martin; Anne Bardoel; Meg E Morris; Leeanne M Carey; Anne E Holland; Katrina M Long; Terry P Haines
Journal:  PLoS Med       Date:  2021-10-22       Impact factor: 11.069

Review 4.  Strategies for disseminating recommendations or guidelines to patients: a systematic review.

Authors:  K Schipper; M Bakker; M De Wit; J C F Ket; T A Abma
Journal:  Implement Sci       Date:  2016-06-07       Impact factor: 7.327

5.  What types of dissemination of information occurred between researchers, providers and clinical staff while implementing an asthma shared decision-making intervention: a directed content analysis.

Authors:  Thomas Ludden; Lindsay Shade; Madelyn Welch; Jacqueline Halladay; Katrina E Donahue; Tamera Coyne-Beasley; Paul Bray; Hazel Tapp
Journal:  BMJ Open       Date:  2020-03-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.